Remove 2015 Remove FDA Remove Fraud Remove Licensing
article thumbnail

Is Your Medical Credentialing Taking Too Long?

Verisys

Primary source verification must be done to confirm a provider’s education, professional license and certifications, medical training, work history, references, and more. Provider information should be continuously monitored for any changes to exclusion or license status. However, verifying a provider’s credentials is essential.

article thumbnail

Is Your Medical Credentialing Taking Too Long?

Verisys

Primary source verification must be done to confirm a provider’s education, professional license and certifications, medical training, work history, references, and more. Provider information should be continuously monitored for any changes to exclusion or license status. Food and Drug Administration (FDA).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Health Provider News

Hall Render

fraud scheme UConn Health is in financial trouble. health care spending hits $4.5

article thumbnail

Health Provider News

Hall Render

Penn Medicine buys Montgomeryville site for $7.5M of Health Won’t Release Details R.I. physicians group partners with Calif. health tech company Lifespan considering $300M bond issue for construction projects R.I.

article thumbnail

Health Provider News

Hall Render

Nevada, currently the wild west of birthing, is considering licensing midwifery NEW HAMPSHIRE Dartmouth Health opens new 5-story patient pavilion Report: Anthem has yet to process nearly $300 million in N.H. no longer calls for masks at all health care facilities to fight COVID-19, Gov.

article thumbnail

The BFDs – The Ten Best Prescription Drug/Medical Device Decisions of 2023

Drug & Device Law

2023) ( Buckman preemption barred MDL asserting fraud on EPA), cert. Since the FDA requires pre-approval of any warnings about off-label uses, preemption at some point should have been pre-ordained under the Mensing ( 2011+1 ) independence principle, but off-label use did not really figure in Zofran ’s analysis. Monsanto Co. ,

FDA 105
article thumbnail

Suing the Certifiers – A Dangerous Undertaking

Drug & Device Law

For qualified IMGs, it issues a certification, which IMGs can then use to apply to residency and other graduate medical education programs and to apply for state medical licenses. The unfortunate truth is that ECFMG was also a victim of this fake doctor’s fraud. 2015 WL 6393869 (S.D. Such power rests solely with the FDA.”

Doctors 52